Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Highlights of This Issue

DOI:  Published December 2014
  • Article
  • Info & Metrics
  • PDF
Loading

HPV in Male Oropharyngeal Cancer

Combes et al. Page 2954

Oropharyngeal cancer (OPC) is more frequent in men than women due to heavier and longer smoking rates in men. To determine if there is a difference in the proportion of human papillomavirus (HPV)–attributable OPC between men and women, Combes and colleagues retrieved HPV prevalence data from 63 OPC studies with gender data. The authors report that the U.S. had the highest M/F ratios of HPV prevalence in OPC, and the lowest M/F ratios were found in Asia. This work confirmed that HPV prevalence in OPC differs by gender and country, most likely as a consequence of male smoking habits.

Physical Activity and Breast Cancer in Africa

Hou et al. Page 2748

Although physical activity (PA) is modifiable and linked to decreased breast cancer risk, its impact has not been investigated among indigenous African populations. Hou and colleagues recruited 558 breast cancer patients to complete a PA questionnaire. PA was significantly associated with reduced breast cancer risk in both pre- and postmenopausal women, with a dose–responsive relationship. The inverse association was present among lean women and overweight women, but not among obese women. PA of African women mainly consists of housework and work-related activities but this preliminary study suggests that modest PA may be significantly associated with reduced breast cancer risk.

HPV Prevalence after Vaccination Initiation

Söderlund-Strand et al. Page 2757

Organized human papillomavirus (HPV) vaccination was introduced in Sweden in 2012 and on-demand vaccination has been in effect from 2006–2011. Söderlund-Strand and colleagues followed HPV prevalences in Sweden from 2008 to 2013. The authors report that among 13- to 22-year-old women, HPV6, 16, and 18 decreased from 2008 to 2013. HPV vaccination rates among 23- to 40-year-old women were lower compared to the younger population and HPV18 decreased only marginally. Major reductions of HPV6, 16, and 18 were found in age groups with concomitant increases in HPV vaccination coverage.

Sex Hormones and Terminal Duct Lobular Units

Khodr et al. Page 2765

Lesser degrees of terminal duct lobular unit (TDLU) involution have been associated with increased breast cancer risk, but factors that influence involution are largely unknown. Khodr and colleagues assessed whether circulating hormones are associated with levels of TDLU involution. Among premenopausal women, higher prolactin levels were associated with higher TDLU counts but higher progesterone was associated with lower TDLU counts. Among postmenopausal women, higher levels of estradiol and testosterone were associated with higher TDLU counts. These data suggest that select hormones may influence breast cancer risk, potentially through delaying TDLU involution.

  • ©2014 American Association for Cancer Research.
Next
Back to top
Cancer Epidemiology Biomarkers & Prevention: 23 (12)
December 2014
Volume 23, Issue 12
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of This Issue
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of This Issue
Cancer Epidemiol Biomarkers Prev December 1 2014 (23) (12) 2619;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Highlights of This Issue
Cancer Epidemiol Biomarkers Prev December 1 2014 (23) (12) 2619;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • HPV in Male Oropharyngeal Cancer
    • Physical Activity and Breast Cancer in Africa
    • HPV Prevalence after Vaccination Initiation
    • Sex Hormones and Terminal Duct Lobular Units
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement